{"nct_id":"NCT03277261","title":"Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 )","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2017-09-19","start_date_type":"ACTUAL","primary_completion_date":"2020-07-23","primary_completion_date_type":"ACTUAL","completion_date":"2020-11-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TGTX"]}